MedPath
NMPA Approval

Benralizumab Injection

国药准字SJ20250007

March 4, 2025

Drug Information

本瑞利珠单抗注射液

凡舒卓

注射剂

单剂量预充式注射器:30mg (1.0 ml)/支

生物制品

March 4, 2025

March 3, 2030

Company Information

Applicant Company

ASTRAZENECA AB

Karlebyhus, Astraallen, Sodertalje, Stockholm SE 151-85 SWEDEN

Manufacturing Company

ASTRAZENECA AB

Gartunavagen, Sodertalje 152 57 SWEDEN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

本瑞利珠单抗注射液 - NMPA 批准文号 | MedPath